Skip to content
Clinical Trials – home
Rare disease

Small cell lung cancer limited stage

  • 8 clinical trials
Quick filters

8 Clinical trials

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tarlatamab
  • Sponsor:Fundacion GECP
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:TIFCEMALIMAB
  • Sponsor:Shanghai Junshi Biosciences Co. Ltd.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Pharmacosmos A/S
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Unicancer
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.